KCA Annual Conference 2025
14-16 October, Adelaide, SA

Speakers

Anne Bannister

Anne Bannister is the Head of Social & Behavioural Sciences at UniQuest, the commercialisation company of The University of Queensland. She specialises in commercialising UQ’s evidence-based technologies and programs which transform the way global communities tackle mental health and wellbeing, chronic disease, public health, education, and ageing, leveraging technology for enabling sustainable delivery at scale. With previous executive management roles in commercial and non-government organisations, her expertise in building businesses based on commercialising IP was developed in her own start-up. Anne has a Bachelor of Commerce from UQ, is a Chartered Accountant, a Justice of the Peace (QLD Qualified), and is a Graduate member of the Australian Institute of Company Directors.

Evelyn Body

Evelyn is  General Manager IP and AI Governance at Xero a SaaS accounting firm. In this role Evelyn has responsibility for leading and guiding Xero's intellectual Property Strategy.  She has extensive experience in the research sector having led commercialisation and investment teams at Auckland UniServices Ltd and is a former KCA board member. Her career has traversed roles in private practice law and patent firms as well as research organisations, TTOs and start ups as such she is well versed in the needs of various players in the commercialisation ecosystem.  Evelyn has been recognised as an expert in this space, having won Kiwinet's commercialisation professional award as well as being recognised in IAM's IP strategy 300. 

Jayden Castillo

Jayden Castillo is the Chief of Staff and Director of Strategy at Quantum Brilliance, an Australian deep tech startup pioneering room-temperature quantum computers and quantum sensors based on diamond NV technology. With a background in scaling deep tech ventures, Jayden plays a key role in strategic planning, capital raising, and customer development, helping bridge the gap between cutting-edge science and commercial outcomes. He is passionate about building autonomous, high-impact teams and driving innovation at the intersection of quantum technology, semiconductors, and advanced manufacturing

Will Charles RTTP

Will Charles has been Executive Director Investment since 2005. In the last six years alone UniServices has started, supported and invested in 43 technology-based companies that have raised nearly $1 billion million in venture and seed funding for these companies. In 2016 he founded and manages the University of Auckland Inventors Fund, a $40m evergreen fund dedicated to start-ups generated by staff and students at the University of Auckland.

Larisa Chisholm

An accomplished life sciences executive, Larisa brings cross-functional expertise from ASX, NASDAQ, academia, not for profit and startup companies.   Larisa spent 14 years at ASX listed Immutep (formerly Prima BioMed) and excels in strategically aligning vaccine research, clinical trials, manufacturing, and commercialisation.An active contributor to advancing education, she supports aspiring students, scientists, and women entrepreneurs through her involvement with the Life Science Springboard program, RMIT Biomedical Science Industry Advisory Committee and Central Pharmacy Logistics.Bachelor of Science (Honours), MBA La Trobe, Australian Institute of Company Directors.

Dave Christensen RTTP

Dave is an experienced manager with responsibility for the University of Otago's commercialisation company - Otago Innovation Ltd. He joined Otago Innovation in 2007 as a commercialisation manager, and subsequently held senior commercialisation manager and GM roles in the organisation, before taking up the reigns as CEO in 2018. Dave has a wealth of experience in assessing, project managing and concluding deals based off of academic research. In addition to managing the company’s day to day activities, Dave has been and continues to be involved in a number of investment committees such as Return on Science’s Biotech & Pharma &Otago Momentum, as well as the Brandon BioCatalyst investment review committee. Dave also serves on various start-up company boards.As the University of Otago's commercialisation company, Otago Innovation is responsible for the identification, protection and transfer of intellectual property generated by academic staff at the University of Otago to newly formed spinout companies or established industry.

Anne-Maree Dowd

Dr. Anne-Maree Dowd, Principal Consultant at Tractuum, is a highly regarded expert in corporate strategy, portfolio and impact management, enterprise performance, and evaluation. She holds a PhD in Organisational Behaviour and has amassed 25 years of experience in scientific research and knowledge mobilisation. Recently, Dr. Dowd co-edited the pivotal book "Cornerstones of Impact Management," collaborating with leading global contributors to advance thought leadership in the field of impact.

Cathy Foley

Dr Cathy Foley AO PSM served as Australia’s Chief Scientist until December 2024, following a distinguished career at CSIRO, including as Chief Scientist. A world-renowned physicist, she led pioneering research in superconductors and sensors, culminating in the LANDTEM mineral exploration system. As Chief Scientist, she advanced national quantum and research strategies. Her leadership and advocacy for women in STEM earned her many accolades, including Fellowship in the Australian Academy of Science and an Order of Australia. She is also a Fellow of ATSE and the Australian Institute of Physics, and remains a powerful advocate for research translation, open access to research literature and scientific excellence.

John Grace AO RTTP

John is an Independent Director on KCA’s board, since joining in 2018 as the representative of UniSA Ventures. He is the Treasurer of KCA and is the Chair of the SCOPR Committee. He has a Bachelor of Science degree from UNSW, a Fellow of the Academy of Technological Sciences and Engineering and a Fellow of the Institute of Company Directors.  John has worked in the biotechnology research commercialisation space for over 50 years.  He was the Chief Executive Officer for 11 years of AMRAD a listed company commercialising medical research technology. He has been a member of many government committees and private company boards. His award as an Officer of the Order of Australia in 2018 was for his contribution to biotechnology research and its commercialisation. 

Lusia Guthrie

With a 45-year career in the pharmaceutical and bioscience industries, Lusia Guthrie is a Company Director who has maintained her passion for innovation, leadership and entrepreneurship. She is a company founder and experienced former CEO. Lusia is a technology developer with a proven track record in translating technologies into commercial outcomes. She is accomplished at defining strategy, raising capital, building teams, fostering cultural change, and maintaining strong internal and external relationships. She has worked and collaborated globally and around Australia.Lusia is presently actively engaged with industry, government, and academia through various board, advisory and mentoring roles, including: Chair of Innovation & Commercial Partners (ICP), the equity holding company of the University of Adelaide; and Chair of Neo-Bionica, a Melbourne-based company serving the global neurotechnology market.Lusia embraces change and life-long learning, giving freely of her time to mentor researchers and emerging entrepreneurs. She is dedicated to advancing the Australian medtech sector and fostering a culture of innovation, collaboration, and excellence. 

Judy Halliday

Dr Judy Halliday is the Director, Innovation and Entrepreneurship in the Department for State Development. In this role, she is responsible for delivering on the Government’s commitment to grow South Australia’s capacity for competitive global excellence in research, translation and commercialisation and to grow entrepreneurship and supporting start-up and scale up business in South Australia.Judy has more than 25 years of executive and management experience in entrepreneurship and innovation as an inventor, founder, investor, academic and industry professional in the private and public sectors. She has published in peerreviewed academic journals and has been successful across many competitive grant programs as both an academic researcher and as an industry partner. She is an inventor on granted patents and has been involved in raising millions of dollars for startup companies. She has negotiated complex multi-million-dollar licensing transactions and collaboration agreements in the development of early-stagetechnologies. 

Michael Harvey

Dr Michael Harvey is the Director of New Ventures at Quantum Australia - Australia's centre for quantum growth - where he operates a national program to stimulate building new quantum businesses and new quantum products in Australia.Michael trained in law and science, and was awarded a PhD in physics from the University of Queensland. Before joining Quantum Australia Michael was the Translational Research Manager for the ARC Centre of Excellence for Engineered Quantum Systems (EQUS) where he built a program with a budget of $3M and created 21 commercial outcomes, including 9 quantum technology startups, with projects bringing in ~$96M in commercial and grant funding. He established similar programs at the Centre of Excellence for Future Low-Energy Electronics Technologies (FLEET) and the Centre of Excellence for Quantum Biotechnology (QUBIC). Prior to joining EQUS Michael was Chief Technology Officer at XeroCoat Inc and Brisbane Materials Technology Pty LtdMichael has lived and worked in Australia, Silicon Valley, Europe, China, & Taiwan, he is a technical advisor to some Australian VC funds, and has co-founded several deep-tech startups in Australia and the USA so far having raised >$60M in venture investment for these businesses. He is an advisor or non-executive director of multiple Australian startups commercialising hydrogen process sensors, power semiconductor devices, quantum data security, low-energy edge AI, superconducting devices, and novel battery chemistries.

Alastair Hick

Dr Alastair Hick is Chief Commercialisation Officer at Monash University, overseeing a successful IP commercialisation program, and developing an ecosystem approach to innovation. He has made exceptional contributions to the field of research commercialisation and innovation throughout a career that spans more than 25 years, marked by significant achievements on an international scale. Formerly Chair of Knowledge Commercialisation Australasia from 2015-2018, and on the Board from 2009-2018, Dr Hick became a Life Member in 2020. In 2023 named Technology Transfer Professional of the Year. He has a PhD in Chemical Ecology, an MBA from Cambridge, and is a Director of multiple Monash spinouts. 

Rock Hudson

David is passionate about the contribution and future of agbiotech to Australian and global agriculture. During a 23 year career with Monsanto, David was actively involved in the development and adoption of conservation tillage by Australian farmers. Since 1996 David has been actively involved in the introduction of Australia’s first agbiotech crops, Ingard® Cotton, Roundup Ready® canola and most recently Super High Oleic Safflower. Since establishing his consulting firm, SGA Solutions in 2006, followed by PTM Solutions in 2014, David has provided consulting services to Australian and international private and public sector clients in the development and implementation of pathway to market strategies for innovative technologies applicable to the grains, horticulture, livestock, forage, forestry and seafood industries. 

Mark Hutchinson

Professor Mark Hutchinson is Director of the Institute for Photonics and Advanced Sensing at the University of Adelaide. A leader in neuroimmunopharmacology and biophotonics,  his research on glial cells has transformed understanding of pain, addiction, and neurological disorders. His research has led to transformative clinical applications, from laboratory concepts to bedside treatments. Mark’s impact extends beyond academic achievements, fostering strong industry partnerships and commercial translations. He holds key national roles, including on the Prime Minister’s National Science and Technology Council, and on the Australia's Economic Accelerator board. 

Seth Jones

Dr Seth Jones is WEHI’s Entrepreneurship Lead, where he played a pivotal role in structuring the IonOpticks deal and led the spinout of Research Code Pty Ltd. With 30 years in technology transfer, he has shaped commercialisation strategy at WEHI and JCU, raised capital for spinouts, and engaged with government on translation policy. He has delivered over $100M in outcomes across biotech, agriculture, and clean energy. Seth has served on eight spinout boards, including as Chair of NutriV Pty Ltd, led complex licensing deals, and coordinated JCU’s Innovation Strategy. He holds a PhD in Biochemistry and is a graduate of the AICD.

Shane Kilcullen

Shane Kilcullen brings a diverse career spanning start-ups, multinationals, and government sectors, with the past seven years focused on university technology transfer at the University of Melbourne. While trained as a mechanical engineer, Shane now navigates an extensive range of technologies across multiple disciplines. He is particularly passionate about artificial intelligence and its potential to enhance professional productivity. Through his leadership of KCA's AI Special Interest Group over the past year, Shane has developed deep insights into the unique challenges and opportunities facing the commercialisation community. This understanding has informed his co-design of this workshop, specifically tailored to help technology transfer professionals maximise AI's impact in their daily practice.

Jonathan Lacey

Jonathan Lacey is co-founder and partner at Cruxes Innovation, which exists to help universities, research organisations, and innovative companies unlock the huge potential of Australian researchers and innovators to make a positive difference in the world. We believe the best way to do this is to work alongside researchers and innovators to build partnerships between research, industry, community groups, and government to solve real-world problems.  Jonathan started his career as a physical science and engineering researcher at the University of Melbourne. He spent 10 years in Silicon Valley where he became fascinated by helping other researchers make a difference in the world with their ideas, in large companies and research spinouts.  He returned to Australia to lead a spinout based on Monash University research.  It raised $10M but failed.  The focus of his career since then has been putting the lessons he learned here to work in creating impact with research.

Andre Luiten

Andre is MD/CTO of QuantX Labs as well as Chief Innovator of the Institute for Photonics and Advanced Sensing (IPAS) and Chair of Experimental Physics at the University of Adelaide. Andre was previously Director of IPAS for over 10 years.Andre is a fellow of the Australian Academy of Technological Sciences & Engineering and the Australian Institute of Physics and has raised over $50M for research. He obtained his PhD in Physics from the University of Western Australia in 1997, for which he was awarded the AIP Bragg Gold Medal. Andre was the joint inaugural winner of the WA Premier’s Prize for Early Career Achievement in Science. In 2013, Andre came to the University of Adelaide to take up a South Australian Research Fellowship from the SA Premier’s Department. In 2016, Andre co-founded a company, QuantX Labs, to exploit his leading-edge research. This company has been profitable from its foundation and now has 42 staff. 

Sanjay Mazumdar

Dr Sanjay Mazumdar is a proven chief executive and board director with over 30 years of experience in the defence, national security and ICT sectors.Sanjay is the Executive Director (Chief Executive) of the Defence Trailblazer, a $200+ million enterprise comprising 100+ industry partners, the University of Adelaide and UNSW, with funding from the Australian Government through the Trailblazer Universities Program.Sanjay’s previous roles include: • Defence and Technology Partner at KPMG Australia• CEO, D2D CRC Ltd • CEO, Defence Systems Innovation Centre• Head of Engineering Operations, BAE Systems Australia• Operations Manager, Motorola• Engineer, DSTO (now DSTG).

Rob McInnes

Rob originally trained as a protein chemist, but has been an intellectual property lawyer for more than 30 years, specialising in IP transactions.  His work mainly involves planning, negotiating and structuring licence agreements and R&D contracts, and conducting due diligence on new technology ventures for investors.Currently Rob is shifting his focus away from legal work and towards angel investing, training, mentoring and advisory committee roles - but he remains active in assisting spinout teams and has helped around 20 spinouts reach agreed terms with their institutions in the past 5 years.

Peter Murphy

Peter is Deputy Vice Chancellor Research & Enterprise at UniSA, and new Pro Vice Chancellor Research Translation at Adelaide University, reflecting his experience in identifying, driving and supporting business development opportunities and translating research discoveries into real-world applications. Peter’s own research encompasses the engineering of surfaces and extends to applications in the optical, automotive, aerospace, defence, mining and renewable energy industry sectors. He has won more than $25 million of research grant funding and was awarded the 2016 ATSE Clunies Ross Award for Innovation for his work in the development of the world’s first plastic, external automotive rear-view mirror.

Melissa Nugent

Melissa Nugent is Chair of the KCA Qld Chapter and a Senior Manager in QUT’s research partnerships and technology transfer office, specializing in agriculture and bioeconomy initiatives. Over her career Mel has led stakeholder engagement portfolios across Higher Education, Government, and NFP sectors – driving innovation and impact through collaboration.Prior to her current role at QUT, she was Director Business Development at ARM Hub, a national not-for-profit advancing manufacturing in Australia through AI and robotics innovation and adoption. Mel is a strong advocate for the role of technology transfer professionals in navigating the challenging path from tech innovation to adoption in important sectors including agriculture. 

David McKeague

David McKeague MBA, Beng (Elec) is a serial venture builder with over 30 years experience in building and commercialising research. Bridging the gap!David has worked in large scale engineering projects including aluminium smelter energy systems both for Boyne Smelters and also Portland Smelter second expansion in automation and plant energy management systems. David has also headed the Systems Engineering for ISCMMS on the Collins Class submarine propulsion, habitability and battery management, F-111 Mission Simulator and has led the Business Development for Australian military C4ISR systems.In addition, David has personally been Venture Building numerous research lab spinouts both at wireless semiconductor (acquired by AMD), embedded AI on the phone funded by Intel Capital, Warner Bros, venture funded voice Gen AI startup and energy storage.

Erin Rayment RTTP

Dr Erin Rayment is Vice-President (Business Development) at QUT and has over 15 years’ experience in academic research, industry engagement and commercialisation. She also holds leadership roles in organisations that support the development and growth of the Australian innovation ecosystem, including as Director at the Translational Research Institute Australia, Director at Knowledge Commercialisation Australasia, Chairperson of QUT Bluebox, and as a Reef Restoration and Adaptation Program board member. An interdisciplinary biologist with expertise in regenerative medicine, cell therapy and bioprocessing, Erin is also a Superstar of STEM, a program that aims to increase the visibility and diversity of women in science, technology, engineering and mathematics. Her mission is to foster collaboration, innovation, and impact across disciplines and sectors.

Carlie Rogers

Carlie Rogers is the Lead for Technology Transfer for the Humanities, Arts and Social Sciences (HASS) at the University of Melbourne, where she champions the commercialisation of research with a strong social purpose. With a background in business development, trade and investment across public and private sectors, Carlie brings a strategic and commercially focused approach to translating HASS research into real-world outcomes. She has been instrumental in helping shape the University’s approach to social ventures and is an advocate for the role of HASS in building more inclusive, purpose-driven innovation ecosystems.

John Rock

John Rock is CEO of Out The Back Ventures, where he partners with leading researchers to uncover high-potential ideas. Known for deep due diligence and sharp commercial instincts, he builds diverse, collaborative teams to turn early-stage research into impactful ventures. With years of experience bridging academia and industry, John specialises in forging partnerships that unlock value and drive real-world outcomes.

Emerald Scofield

Emerald is an Associate at Main Sequence Ventures, where she backs deep-tech founders and helps scale groundbreaking companies with the potential to change the world.With six years in deep-tech investing, Emerald focuses on Feeding 10 Billion People, Decarbonising the Planet, and Humanity Scale Healthcare. She is deeply involved in early-stage investment and company building, backing founders to turn cutting-edge science into real-world impact while also supporting companies as they scale.Before joining Main Sequence, she invested in deep tech at a New Zealand-based fund, working across similar sectors. Emerald has also been on the startup side—working to scale a medtech company and leading an early-stage climate tech startup—experiences that built a strong sense of founder empathy and an appreciation for the highs and lows of building a company.

Elaine Stead

Elaine Stead is a member of the investment team at Main Sequence, with a focus on the “Humanity Scale Healthcare” challenge. With a background spanning science, entrepreneurship, and venture capital, she's known for her enduring roles in innovation and has an investment track record that extends to over 80 startups across Australia, the United States and Southeast Asia.  Previously, Elaine served as the Director of New Ventures and Entrepreneurship at the Australian National University (ANU), leading the startup and equity investment strategy of knowledge translation. She has also been a founder of venture businesses, including Blue Sky VC, Human VC and Tribe Global Ventures.Elaine has advised state governments on innovation policy, directed innovation initiatives, and served on boards in Australia and the US. She's coached startup founders nationwide and contributed to a variety of publications. In all avenues, Elaine prioritises human-centricity, emphasising authentic connections, vulnerability, and compassion. She advocates for values-driven innovation and a desire to make better that which can be.Elaine holds a Ph.D. in Biochemistry (Stem Cell Biology) and a B.Sc.in Biochemistry and Microbiology, both from the University of Adelaide.

Kate Taylor RTTP

Kate Taylor is Executive Director of Industry Engagement at Queensland University of Technology (QUT), where she leads efforts to drive strategic research partnerships, foster innovation, and commercialise QUT’s intellectual property. With over 13 years of experience in technology transfer and business development, Kate’s experience spans diverse sectors including health, agriculture, defence, education, and creative industries, all aimed at delivering impactful, real-world outcomes. Kate is a Registered Technology Transfer Professional and holds a Bachelor of Biotechnology (First Class Honours) from the University of Queensland. She is also a graduate of the Australian Institute of Company Directors. In addition to her role at QUT, Kate serves on the board of the Queensland Social Enterprise Council and chairs the Queensland Network Chapter of Knowledge Commercialisation Australasia. Recognised as an AgriFutures Future Young Leader in 2019, Kate is committed to fostering collaboration and entrepreneurship across sectors. 

Steve Trench

Steve Trench, Santos Executive Vice President, Operations and Technical Services Corporate Function. He is responsible for global operations and technical management systems, capabilities and performance oversight across, health, safety and environment, production operations, projects and supply chain and innovation. Santos operates across Australia, PNG, Timor Leste and North America. Steve has 25 years of global experience in the oil and gas industry. Before joining Santos, he spent 22 years at Woodside Energy where he held technical and operational leadership roles, including leadership of the North West Shelf Project’s Karratha LNG asset. Steve also served in strategy, business management and governance roles, including as Vice President of Strategy, Planning and Analysis.

Ryan Williams

Ryan is the Director of the Australian Centre for Business Growth at UniSA and Chair of Southern Angels. He has held several CEO, Managing Director and Executive positions across a broad range of sectors including Group CEO of Unlimited, a private equity accelerator housing 16 investee companies and CEO of Ster-Kinekor Theatres, Africa’s largest cinema chain. Ryan has held several Chair and Board roles since 2008, and in addition to Southern Angels, currently serves as a Non-Executive Director at Ster-Kinekor Theatres and is a member of the Advisory Board for MarketEase, a leading digital marketing consultancy based in Adelaide. 

Thank you to our Sponsors

Gold Sponsor


Coffee Cart Sponsor



Silver Sponsor




Welcome Reception Sponsor


Dinner & Award Night Sponsor

 




Merchandise Sponsor



Contact:

KCA Professional Conference Organiser
P: 02 9431 8600
E: conference@techtransfer.org.au

© Copyright 2023 KCA Annual Conference